The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
Corvus increased its public stock offering to $175 million from $150 million, making 7.9 million shares of its common stock ...
Pandemic disruption caused diagnosis rates to plummet for many conditions – and some still haven’t recovered five years later ...
Clinical-stage biopharmaceutical company Corvus Pharmaceuticals (CRVS) priced an upsized underwritten public offering of .9M ...
Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 7,900,677 shares of its common stock ...
Vanda Pharmaceuticals Inc. company and executive profile by Barron's. View the latest VNDA company infomation and executive bios.
The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...
Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria's stockholders held on January 21, 2026, Astria's stockholders voted to approve the acquisition of Astria ...
Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
Children who have multiple food allergies (FAs) and allergies to milk and eggs are more likely to have early-onset atopic dermatitis (AD).
How do early-life exposures shape the infant skin microbiome and atopic dermatitis risk? New cohort data reveal key ...
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...